Clinical Trials Browser

Recruiting × Interventional × AP 1903 reagent × Clear all

NCT06358430 2026-05-20

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT07598955 2026-05-20

SELECT-NK-THYM

Phase 1/2 Recruiting

Thymic epithelial tumor, Thymoma